Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 3895K) PPT slides of all figures Supplemental Material Index Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Arita, M. Articles by Serhan, C. N. Search for Related Content PubMed PubMed Citation Articles by Arita, M. Articles by Serhan, C. N. Related Collections Related Articles Social Bookmarking                            What's this?

¹ Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative, and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115
² Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892
³ Department of Chemistry and Loker Hydrocarbon Research Institute, University of Southern California, Los Angeles, CA 90089

CORRESPONDENCE Charles N. Serhan: cnserhan{at}zeus.bwh.harvard.edu

The essential fatty acid eicosapentaenoic acid (EPA) present in fish oils displays beneficial effects in a range of human disorders associated with inflammation including cardiovascular disease. Resolvin E1 (RvE1), a new bioactive oxygenated product of EPA, was identified in human plasma and prepared by total organic synthesis. Results of bioaction and physical matching studies indicate that the complete structure of RvE1 is 5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-EPA. At nanomolar levels, RvE1 dramatically reduced dermal inflammation, peritonitis, dendritic cell (DC) migration, and interleukin (IL) 12 production. We screened receptors and identified one, denoted earlier as ChemR23, that mediates RvE1 signal to attenuate nuclear factor–B. Specific binding of RvE1 to this receptor was confirmed using synthetic [³H]-labeled RvE1. Treatment of DCs with small interference RNA specific for ChemR23 sharply reduced RvE1 regulation of IL-12. These results demonstrate novel counterregulatory responses in inflammation initiated via RvE1 receptor activation that provide the first evidence for EPA-derived potent endogenous agonists of antiinflammation.

Abbreviations used: -3 PUFA, omega-3 polyunsaturated fatty acid; COX, cyclooxygenase; EAR, extracellular acidification rate; EPA, eicosapentaenoic acid; ERK, extracellular signal-regulated kinase; GPCR, G-protein–coupled receptor; HEPE, hydroxyeicosapentaenoic acid; LC-MS/MS, liquid chromatography tandem mass spectrometry; LO, lipoxygenase; LXA₄, lipoxin A₄; MAP, mitogen-activated protein; PTX, pertussis toxin; RvE1, resolvin E1; siRNA, small interference RNA; STAg, soluble tachyzoite antigen.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

Related Articles

Controlling inflammation: a fat chance?

Roderick J. Flower and Mauro Perretti
J. Exp. Med. 2005 201: 671-674. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

• Luangsay, S., Wittamer, V., Bondue, B., De Henau, O., Rouger, L., Brait, M., Franssen, J.-D., de Nadai, P., Huaux, F., Parmentier, M. (2009). Mouse ChemR23 Is Expressed in Dendritic Cell Subsets and Macrophages, and Mediates an Anti-Inflammatory Activity of Chemerin in a Lung Disease Model. J. Immunol. 183: 6489-6499 [Abstract] [Full Text]  
• Jin, Y., Arita, M., Zhang, Q., Saban, D. R., Chauhan, S. K., Chiang, N., Serhan, C. N., Dana, R. (2009). Anti-angiogenesis Effect of the Novel Anti-inflammatory and Pro-resolving Lipid Mediators. IOVS 50: 4743-4752 [Abstract] [Full Text]  
• Waitzberg, D. L., Torrinhas, R. S. (2009). Fish Oil Lipid Emulsions and Immune Response: What Clinicians Need to Know. Nutr Clin Pract 24: 487-499 [Abstract] [Full Text]  
• Tian, H., Lu, Y., Sherwood, A. M., Hongqian, D., Hong, S. (2009). Resolvins E1 and D1 in Choroid-Retinal Endothelial Cells and Leukocytes: Biosynthesis and Mechanisms of Anti-inflammatory Actions. IOVS 50: 3613-3620 [Abstract] [Full Text]  
• Gonzalez-Periz, A., Horrillo, R., Ferre, N., Gronert, K., Dong, B., Moran-Salvador, E., Titos, E., Martinez-Clemente, M., Lopez-Parra, M., Arroyo, V., Claria, J. (2009). Obesity-induced insulin resistance and hepatic steatosis are alleviated by {omega}-3 fatty acids: a role for resolvins and protectins. FASEB J. 23: 1946-1957 [Abstract] [Full Text]  
• Mayer, K., Kiessling, A., Ott, J., Schaefer, M. B., Hecker, M., Henneke, I., Schulz, R., Gunther, A., Wang, J., Wu, L., Roth, J., Seeger, W., Kang, J. X. (2009). Acute Lung Injury Is Reduced in fat-1 Mice Endogenously Synthesizing n-3 Fatty Acids. Am. J. Respir. Crit. Care Med. 179: 474-483 [Abstract] [Full Text]  
• Pierce, R. A., Perrone, J. M., Nimeri, A., Sexton, J. A., Walcutt, J., Frisella, M. M., Matthews, B. D. (2009). 120-Day Comparative Analysis of Adhesion Grade and Quantity, Mesh Contraction, and Tissue Response to a Novel Omega-3 Fatty Acid Bioabsorbable Barrier Macroporous Mesh After Intraperitoneal Placement. SURG INNOV 16: 46-54 [Abstract]  
• Serhan, C. N., Yang, R., Martinod, K., Kasuga, K., Pillai, P. S., Porter, T. F., Oh, S. F., Spite, M. (2009). Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. JEM 206: 15-23 [Abstract] [Full Text]  
• Kasuga, K., Yang, R., Porter, T. F., Agrawal, N., Petasis, N. A., Irimia, D., Toner, M., Serhan, C. N. (2008). Rapid Appearance of Resolvin Precursors in Inflammatory Exudates: Novel Mechanisms in Resolution. J. Immunol. 181: 8677-8687 [Abstract] [Full Text]  
• Vassiliou, E. K., Kesler, O. M., Tadros, J. H., Ganea, D. (2008). Bone Marrow-Derived Dendritic Cells Generated in the Presence of Resolvin E1 Induce Apoptosis of Activated CD4+ T Cells. J. Immunol. 181: 4534-4544 [Abstract] [Full Text]  
• Yoshimura, T., Oppenheim, J. J. (2008). Chemerin reveals its chimeric nature. JEM 205: 2187-2190 [Abstract] [Full Text]  
• Erridge, C., Kennedy, S., Spickett, C. M., Webb, D. J. (2008). Oxidized Phospholipid Inhibition of Toll-like Receptor (TLR) Signaling Is Restricted to TLR2 and TLR4: ROLES FOR CD14, LPS-BINDING PROTEIN, AND MD2 AS TARGETS FOR SPECIFICITY OF INHIBITION. J. Biol. Chem. 283: 24748-24759 [Abstract] [Full Text]  
• Dona, M., Fredman, G., Schwab, J. M., Chiang, N., Arita, M., Goodarzi, A., Cheng, G., von Andrian, U. H., Serhan, C. N. (2008). Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets. Blood 112: 848-855 [Abstract] [Full Text]  
• Cash, J. L., Hart, R., Russ, A., Dixon, J. P.C., Colledge, W. H., Doran, J., Hendrick, A. G., Carlton, M. B.L., Greaves, D. R. (2008). Synthetic chemerin-derived peptides suppress inflammation through ChemR23. JEM 205: 767-775 [Abstract] [Full Text]  
• Marion-Letellier, R., Butler, M., Dechelotte, P., Playford, R. J, Ghosh, S. (2008). Comparison of cytokine modulation by natural peroxisome proliferator-activated receptor {gamma} ligands with synthetic ligands in intestinal-like Caco-2 cells and human dendritic cells--potential for dietary modulation of peroxisome proliferator-activated receptor {gamma} in intestinal inflammation . Am. J. Clin. Nutr. 87: 939-948 [Abstract] [Full Text]  
• Hong, S., Porter, T. F., Lu, Y., Oh, S. F., Pillai, P. S., Serhan, C. N. (2008). Resolvin E1 Metabolome in Local Inactivation during Inflammation-Resolution. J. Immunol. 180: 3512-3519 [Abstract] [Full Text]  
• Kalsotra, A., Du, L., Wang, Y., Ladd, P. A., Kikuta, Y., Duvic, M., Boyd, A. S., Keeney, D. S., Strobel, H. W. (2008). Inflammation resolved by retinoid X receptor-mediated inactivation of leukotriene signaling pathways. FASEB J. 22: 538-547 [Abstract] [Full Text]  
• Hasturk, H., Kantarci, A., Goguet-Surmenian, E., Blackwood, A., Andry, C., Serhan, C. N., Van Dyke, T. E. (2007). Resolvin E1 Regulates Inflammation at the Cellular and Tissue Level and Restores Tissue Homeostasis In Vivo. J. Immunol. 179: 7021-7029 [Abstract] [Full Text]  
• Haworth, O., Levy, B. D. (2007). Endogenous lipid mediators in the resolution of airway inflammation. Eur Respir J 30: 980-992 [Abstract] [Full Text]  
• Campbell, E. L., Louis, N. A., Tomassetti, S. E., Canny, G. O., Arita, M., Serhan, C. N., Colgan, S. P. (2007). Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution. FASEB J. 21: 3162-3170 [Abstract] [Full Text]  
• Nowak, J., Weylandt, K. H., Habbel, P., Wang, J., Dignass, A., Glickman, J. N., Kang, J. X. (2007). Colitis-associated colon tumorigenesis is suppressed in transgenic mice rich in endogenous n-3 fatty acids. Carcinogenesis 28: 1991-1995 [Abstract] [Full Text]  
• Arita, M., Ohira, T., Sun, Y.-P., Elangovan, S., Chiang, N., Serhan, C. N. (2007). Resolvin E1 Selectively Interacts with Leukotriene B4 Receptor BLT1 and ChemR23 to Regulate Inflammation. J. Immunol. 178: 3912-3917 [Abstract] [Full Text]  
• Shaikh, S. R., Edidin, M. (2006). Polyunsaturated fatty acids, membrane organization, T cells, and antigen presentation. Am. J. Clin. Nutr. 84: 1277-1289 [Abstract] [Full Text]  
• Gonzalez-Periz, A., Planaguma, A., Gronert, K., Miquel, R., Lopez-Parra, M., Titos, E., Horrillo, R., Ferre, N., Deulofeu, R., Arroyo, V., Rodes, J., Claria, J. (2006). Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA. FASEB J. 20: 2537-2539 [Abstract] [Full Text]  
• Chiang, N., Serhan, C. N., Dahlen, S.-E., Drazen, J. M., Hay, D. W. P., Rovati, G. E., Shimizu, T., Yokomizo, T., Brink, C. (2006). The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo. Pharmacol. Rev. 58: 463-487 [Abstract] [Full Text]  
• Arita, M., Oh, S. F., Chonan, T., Hong, S., Elangovan, S., Sun, Y.-P., Uddin, J., Petasis, N. A., Serhan, C. N. (2006). Metabolic Inactivation of Resolvin E1 and Stabilization of Its Anti-inflammatory Actions. J. Biol. Chem. 281: 22847-22854 [Abstract] [Full Text]  
• Lee, S., Gura, K. M., Kim, S., Arsenault, D. A., Bistrian, B. R., Puder, M. (2006). Current Clinical Applications of {Omega}-6 and {Omega}-3 Fatty Acids. Nutr Clin Pract 21: 323-341 [Abstract] [Full Text]  
• Hudert, C. A., Weylandt, K. H., Lu, Y., Wang, J., Hong, S., Dignass, A., Serhan, C. N., Kang, J. X. (2006). Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc. Natl. Acad. Sci. USA 103: 11276-11281 [Abstract] [Full Text]  
• Friedman, A., Moe, S. (2006). Review of the Effects of Omega-3 Supplementation in Dialysis Patients. CJASN 1: 182-192 [Abstract] [Full Text]  
• Arita, M., Yoshida, M., Hong, S., Tjonahen, E., Glickman, J. N., Petasis, N. A., Blumberg, R. S., Serhan, C. N. (2005). Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc. Natl. Acad. Sci. USA 102: 7671-7676 [Abstract] [Full Text]  
• Arita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., Yang, R., Petasis, N. A., Serhan, C. N. (2005). Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. JCB 168: i14-i14 [Full Text]  
• Flower, R. J., Perretti, M. (2005). Controlling inflammation: a fat chance?. JEM 201: 671-674 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS